190 related articles for article (PubMed ID: 26313459)
1. Hepatitis C Virus Driven AXL Expression Suppresses the Hepatic Type I Interferon Response.
Read SA; Tay ES; Shahidi M; O'Connor KS; Booth DR; George J; Douglas MW
PLoS One; 2015; 10(8):e0136227. PubMed ID: 26313459
[TBL] [Abstract][Full Text] [Related]
2. The Mechanism of Interferon Refractoriness During Hepatitis C Virus Infection and Its Reversal with a Peroxisome Proliferator-Activated Receptor α Agonist.
Read SA; Tay ES; Shahidi M; McLauchlan J; George J; Douglas MW
J Interferon Cytokine Res; 2015 Jun; 35(6):488-97. PubMed ID: 25734487
[TBL] [Abstract][Full Text] [Related]
3. Defective hepatic response to interferon and activation of suppressor of cytokine signaling 3 in chronic hepatitis C.
Huang Y; Feld JJ; Sapp RK; Nanda S; Lin JH; Blatt LM; Fried MW; Murthy K; Liang TJ
Gastroenterology; 2007 Feb; 132(2):733-44. PubMed ID: 17258724
[TBL] [Abstract][Full Text] [Related]
4. Hepatic IFNL4 expression is associated with non-response to interferon-based therapy through the regulation of basal interferon-stimulated gene expression in chronic hepatitis C patients.
Murakawa M; Asahina Y; Kawai-Kitahata F; Nakagawa M; Nitta S; Otani S; Nagata H; Kaneko S; Asano Y; Tsunoda T; Miyoshi M; Itsui Y; Azuma S; Kakinuma S; Tanaka Y; Iijima S; Tsuchiya K; Izumi N; Tohda S; Watanabe M
J Med Virol; 2017 Jul; 89(7):1241-1247. PubMed ID: 28036111
[TBL] [Abstract][Full Text] [Related]
5. HCV infection induces a unique hepatic innate immune response associated with robust production of type III interferons.
Thomas E; Gonzalez VD; Li Q; Modi AA; Chen W; Noureddin M; Rotman Y; Liang TJ
Gastroenterology; 2012 Apr; 142(4):978-88. PubMed ID: 22248663
[TBL] [Abstract][Full Text] [Related]
6. Type III Interferon Induces Distinct SOCS1 Expression Pattern that Contributes to Delayed but Prolonged Activation of Jak/STAT Signaling Pathway: Implications for Treatment Non-Response in HCV Patients.
Liu B; Chen S; Guan Y; Chen L
PLoS One; 2015; 10(7):e0133800. PubMed ID: 26193702
[TBL] [Abstract][Full Text] [Related]
7. Feedback regulation of IFN-α/β signaling by Axl receptor tyrosine kinase modulates HBV immunity.
Huang MT; Liu WL; Lu CW; Huang JJ; Chuang HL; Huang YT; Horng JH; Liu P; Han DS; Chiang BL; Shih C; Chen PJ; Chen DS
Eur J Immunol; 2015 Jun; 45(6):1696-705. PubMed ID: 25820812
[TBL] [Abstract][Full Text] [Related]
8. Malnutrition impairs interferon signaling through mTOR and FoxO pathways in patients with chronic hepatitis C.
Honda M; Takehana K; Sakai A; Tagata Y; Shirasaki T; Nishitani S; Muramatsu T; Yamashita T; Nakamoto Y; Mizukoshi E; Sakai Y; Yamashita T; Nakamura M; Shimakami T; Yi M; Lemon SM; Suzuki T; Wakita T; Kaneko S;
Gastroenterology; 2011 Jul; 141(1):128-40, 140.e1-2. PubMed ID: 21458454
[TBL] [Abstract][Full Text] [Related]
9. Non-response to antiviral therapy is associated with obesity and increased hepatic expression of suppressor of cytokine signalling 3 (SOCS-3) in patients with chronic hepatitis C, viral genotype 1.
Walsh MJ; Jonsson JR; Richardson MM; Lipka GM; Purdie DM; Clouston AD; Powell EE
Gut; 2006 Apr; 55(4):529-35. PubMed ID: 16299039
[TBL] [Abstract][Full Text] [Related]
10. IL-29 is the dominant type III interferon produced by hepatocytes during acute hepatitis C virus infection.
Park H; Serti E; Eke O; Muchmore B; Prokunina-Olsson L; Capone S; Folgori A; Rehermann B
Hepatology; 2012 Dec; 56(6):2060-70. PubMed ID: 22706965
[TBL] [Abstract][Full Text] [Related]
11. Hepatic metallothionein expression in chronic hepatitis C virus infection is IFNL3 genotype-dependent.
O'Connor KS; Parnell G; Patrick E; Ahlenstiel G; Suppiah V; van der Poorten D; Read SA; Leung R; Douglas MW; Yang JY; Stewart GJ; Liddle C; George J; Booth DR
Genes Immun; 2014 Mar; 15(2):88-94. PubMed ID: 24335707
[TBL] [Abstract][Full Text] [Related]
12. Hepatic expression levels of interferons and interferon-stimulated genes in patients with chronic hepatitis C: A phenotype-genotype correlation study.
Noureddin M; Rotman Y; Zhang F; Park H; Rehermann B; Thomas E; Liang TJ
Genes Immun; 2015; 16(5):321-9. PubMed ID: 26020282
[TBL] [Abstract][Full Text] [Related]
13. Lack of response to exogenous interferon-alpha in the liver of chimpanzees chronically infected with hepatitis C virus.
Lanford RE; Guerra B; Bigger CB; Lee H; Chavez D; Brasky KM
Hepatology; 2007 Oct; 46(4):999-1008. PubMed ID: 17668868
[TBL] [Abstract][Full Text] [Related]
14. Impact of host IL28B rs12979860, rs8099917 in interferon responsiveness and advanced liver disease in chronic genotype 3 hepatitis C patients.
Firdaus R; Biswas A; Saha K; Mukherjee A; Chaudhuri S; Chandra A; Konar A; Sadhukhan PC
PLoS One; 2014; 9(6):e99126. PubMed ID: 24914551
[TBL] [Abstract][Full Text] [Related]
15. Effect of ethanol on innate antiviral pathways and HCV replication in human liver cells.
Plumlee CR; Lazaro CA; Fausto N; Polyak SJ
Virol J; 2005 Dec; 2():89. PubMed ID: 16324217
[TBL] [Abstract][Full Text] [Related]
16. Impaired interferon signaling in chronic hepatitis C patients with advanced fibrosis via the transforming growth factor beta signaling pathway.
Shirasaki T; Honda M; Shimakami T; Murai K; Shiomoto T; Okada H; Takabatake R; Tokumaru A; Sakai Y; Yamashita T; Lemon SM; Murakami S; Kaneko S
Hepatology; 2014 Nov; 60(5):1519-30. PubMed ID: 24962339
[TBL] [Abstract][Full Text] [Related]
17. Hepatitis C virus kinetics by administration of pegylated interferon-α in human and chimeric mice carrying human hepatocytes with variants of the IL28B gene.
Watanabe T; Sugauchi F; Tanaka Y; Matsuura K; Yatsuhashi H; Murakami S; Iijima S; Iio E; Sugiyama M; Shimada T; Kakuni M; Kohara M; Mizokami M
Gut; 2013 Sep; 62(9):1340-6. PubMed ID: 23135762
[TBL] [Abstract][Full Text] [Related]
18. Suppressor of cytokine signaling 3 (SOCS3) expression and hepatitis C virus-related chronic hepatitis: Insulin resistance and response to antiviral therapy.
Persico M; Capasso M; Persico E; Svelto M; Russo R; Spano D; Crocè L; La Mura V; Moschella F; Masutti F; Torella R; Tiribelli C; Iolascon A
Hepatology; 2007 Oct; 46(4):1009-15. PubMed ID: 17668875
[TBL] [Abstract][Full Text] [Related]
19. Suppressor of cytokine signaling 3 suppresses hepatitis C virus replication in an mTOR-dependent manner.
Shao RX; Zhang L; Peng LF; Sun E; Chung WJ; Jang JY; Tsai WL; Hyppolite G; Chung RT
J Virol; 2010 Jun; 84(12):6060-9. PubMed ID: 20375166
[TBL] [Abstract][Full Text] [Related]
20. Understanding the molecular mechanism(s) of hepatitis C virus (HCV) induced interferon resistance.
Qashqari H; Al-Mars A; Chaudhary A; Abuzenadah A; Damanhouri G; Alqahtani M; Mahmoud M; El Sayed Zaki M; Fatima K; Qadri I
Infect Genet Evol; 2013 Oct; 19():113-9. PubMed ID: 23831932
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
